Skip to content

Neural Indices Associated With Relapse in Cannabis Dependence

Altered Neural Activation Patterns of Emotional Processing in Dependent Cannabis Users Associated With Relapse

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02801422
Enrollment
75
Registered
2016-06-15
Start date
2016-02-29
Completion date
2019-03-31
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis Dependence

Keywords

cannabis, fMRI, addiction, relapse

Brief summary

The aim of this fMRI study is to investigate neural indices of relapse in cannabis dependence. The development and maintenance of drug addictions have been associated with deficits in cognitive control, craving and impaired stress regulation. Therefore, neural markers of brain processes underlying the beforementioned components will be studied. Subsequent follow-up drug use interviews will reveal associations between relapse in cannabis dependence and alterations in brain networks of cognitive control, craving and stress.

Interventions

OTHERfMRI

Sponsors

German Research Foundation
CollaboratorOTHER
University Hospital, Bonn
CollaboratorOTHER
University of Electronic Science and Technology of China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Cannabis Dependence * 24 hours abstinence

Exclusion criteria

* other DSM-4 diagnosis * neurological disorder

Design outcomes

Primary

MeasureTime frameDescription
fMRI neural activation patterns of emotional processingone time point = fMRI assessment after minimum 24 hours of abstinenceActivation patterns associated with emotion processing, emotion regulation, craving and stress are determined in addicted cannabis users compared to non-using matched control subjects

Secondary

MeasureTime frameDescription
Timeline Followback Interviewsone time point = 12 months after fMRI data acquisitionAssociation between fMRI correlates and drug use during follow up preiod as predictor for relapse

Countries

Germany

Contacts

Primary ContactBenjamin Becker, PhD
ben_becker@gmx.de+8618584070309
Backup ContactKaeli Zimmermann, MSc
kaeli.zimmermann@gmx.de+49022828719704

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026